Comment on Albogami et al. Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344-1352.
作者信息
Foer Dinah, Cahill Katherine N
机构信息
Division of Allergy and Clinical Immunology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN.
出版信息
Diabetes Care. 2021 Aug;44(8):e165-e166. doi: 10.2337/dc21-0904. Epub 2021 Jul 20.
Abstract
摘要
相似文献
1
Comment on Albogami et al. Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344-1352.对阿尔博加米等人的评论。2型糖尿病患者中胰高血糖素样肽1受体激动剂与慢性下呼吸道疾病急性加重。《糖尿病护理》2021年；44:1344 - 1352。
Diabetes Care. 2021 Aug;44(8):e165-e166. doi: 10.2337/dc21-0904. Epub 2021 Jul 20.
2
Response to Comment on Albogami et al. Glucagon-Like Peptide-1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344-1352.对关于阿尔博加米等人的评论的回应。2型糖尿病患者中胰高血糖素样肽-1受体激动剂与慢性下呼吸道疾病加重。《糖尿病护理》2021年；44:1344 - 1352。
Diabetes Care. 2021 Aug;44(8):e167. doi: 10.2337/dci21-0024. Epub 2021 Jul 20.
3
Glucagon like peptide-1 and its receptor agonists: Their roles in management of Type 2 diabetes mellitus.胰高血糖素样肽-1及其受体激动剂：它们在2型糖尿病管理中的作用。
Diabetes Metab Syndr. 2017 Jul-Sep;11(3):225-230. doi: 10.1016/j.dsx.2016.09.003. Epub 2016 Sep 15.
4
New Injectable Agents for the Treatment of Type 2 Diabetes Part 2-Glucagon-Like Peptide-1 (GLP-1) Agonists.新型 2 型糖尿病治疗药物 第 2 部分：胰高血糖素样肽-1（GLP-1）激动剂。
Am J Med. 2018 Nov;131(11):1304-1306. doi: 10.1016/j.amjmed.2018.05.043. Epub 2018 Jul 2.
5
Cigarette smoking, type 2 diabetes mellitus, and glucagon-like peptide-1 receptor agonists as a potential treatment for smokers with diabetes: An integrative review.吸烟、2 型糖尿病与胰高血糖素样肽-1 受体激动剂作为糖尿病吸烟者的潜在治疗方法：综合评价。
Diabetes Res Clin Pract. 2019 Mar;149:78-88. doi: 10.1016/j.diabres.2019.01.033. Epub 2019 Feb 5.
6
Reply to Watchorn : Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes.对沃乔恩的回复：2型糖尿病患者使用胰高血糖素样肽-1受体激动剂时的哮喘加重情况
Am J Respir Crit Care Med. 2021 Apr 1;203(7):924-925. doi: 10.1164/rccm.202012-4511LE.
7
Severe acute renal failure in patients treated with glucagon-like peptide-1 receptor agonists.胰高血糖素样肽-1 受体激动剂治疗患者的严重急性肾衰竭。
Diabetes Res Clin Pract. 2014 Mar;103(3):e53-5. doi: 10.1016/j.diabres.2013.11.014. Epub 2013 Nov 20.
8
Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors.胰高血糖素样肽-1 受体激动剂和二肽基肽酶-4 抑制剂的心血管作用和临床结局。
Circulation. 2017 Aug 29;136(9):849-870. doi: 10.1161/CIRCULATIONAHA.117.028136.
9
Emerging therapies mimicking the effects of amylin and glucagon-like peptide 1.模拟胰淀素和胰高血糖素样肽1作用的新兴疗法。
Diabetes Care. 2006 Feb;29(2):435-49. doi: 10.2337/diacare.29.02.06.dc05-1267.
10
Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate.心脏再同步治疗伴或不伴除颤器（CRTd）在 2 型糖尿病衰竭心脏患者中的应用：胰高血糖素样肽 1 受体激动剂（GLP-1 RA）治疗与常规降糖药物治疗的比较——心律失常负担、心力衰竭住院率和 CRTd 应答率。
Cardiovasc Diabetol. 2018 Oct 22;17(1):137. doi: 10.1186/s12933-018-0778-9.
引用本文的文献
1
Glucagon-like Peptide 1 Receptor Agonists and Asthma Exacerbations: Which Patients Benefit Most?胰高血糖素样肽-1 受体激动剂与哮喘恶化：哪些患者获益最大？
Ann Am Thorac Soc. 2024 Nov;21(11):1496-1506. doi: 10.1513/AnnalsATS.202309-836OC.
本文引用的文献
1
Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes.胰高血糖素样肽 1 受体激动剂与 2 型糖尿病患者慢性下呼吸道疾病加重的关系。
Diabetes Care. 2021 Jun;44(6):1344-1352. doi: 10.2337/dc20-1794. Epub 2021 Apr 19.
2
Diabetes Mellitus Is Associated with Worse Outcome in Patients Hospitalized for Asthma.糖尿病与因哮喘住院患者的更差预后相关。
J Allergy Clin Immunol Pract. 2021 Apr;9(4):1562-1569.e1. doi: 10.1016/j.jaip.2020.10.054. Epub 2020 Nov 9.
3
Asthma Exacerbations in Patients with Type 2 Diabetes and Asthma on Glucagon-like Peptide-1 Receptor Agonists.2 型糖尿病合并哮喘患者使用胰高血糖素样肽-1 受体激动剂后哮喘加重。
Am J Respir Crit Care Med. 2021 Apr 1;203(7):831-840. doi: 10.1164/rccm.202004-0993OC.
4
Glucagon-like peptide 1 signaling inhibits allergen-induced lung IL-33 release and reduces group 2 innate lymphoid cell cytokine production in vivo.胰高血糖素样肽 1 信号抑制变应原诱导的肺 IL-33 释放，并减少体内 2 型先天淋巴细胞细胞因子的产生。
J Allergy Clin Immunol. 2018 Nov;142(5):1515-1528.e8. doi: 10.1016/j.jaci.2017.11.043. Epub 2018 Jan 10.
Zotero 插件